Super Bowl

Pharma Giant Valeant Enters the Super Bowl Fray With a Toe Fungus Ad

30-second ad for Jublia will air in the 3rd quarter

A toe treatment gets into the big game.

Interesting Super Bowl advertising news is afoot.

Valeant Pharmaceuticals International is running a 30-second spot during the big game's third quarter, Adweek has learned. The ad will push Jublia, a topical solution approved last June by the Food and Drug Administration that's designed to treat onychomycosis, a fungal infection of toe nails. 

The spot, "Tackle It," was created by healthcare shop Harrison and Star and will feature football-themed animation from digital shop Th1ng. The brand's marketers don't plan to tease its commercial before it appears during Sunday's game.

Valeant's Super Bowl ad purchase—which will cost roughly $4.5 million—comes on the heels of a Reuters article from December that indicated that the Quebec-based company wanted to push Jublia and a few other new products hard while it scales back on acquisitions. 

The billion-dollar pharma player, which develops products in neurology, dermatology and branded generics, said the commercial represents an evolution of Jublia's ongoing multichannel campaign, which includes digital and print ads. 

Adweek Blog Network